The FDA subsequently announced a timeline for when most compounded versions may no longer be made
However, oral weight-loss medications do exist: oral Wegovy (semaglutide) was approved in late 2025, and Foundayo (orforglipron), an oral GLP-1 pill from Eli Lilly, was FDA-approved in April 2026
Why this matters for 100-unit calculations If a friend on a branded Ozempic pen tells you they take "1 mg weekly" and you try to replicate that from your compounded vial, you need YOUR vial concentration, not theirs
Plus your care team, monitoring & cellular smart scale covered by Medicare
Virtual healthcare platforms like Ogaei offer several advantages when exploring semaglutide treatment: Accessible Expert Guidance: You can consult with healthcare providers who understand provincial coverage differences, private insurance requirements, and cost-reduction strategies, all from your home, without clinic wait times
In clinical trials, optimal weight loss was seen in patients on the 15mg dose of Mounjaro